MoonLake ImmunotherapeuticsMLTXNASDAQ
Loading
Debt to Equity Over TimeElevated
Percentile Rank100
3Y CAGR+250.4%
5Y CAGR+244.0%
Year-over-Year Change
Debt-to-equity ratio
3Y CAGR
+250.4%/yr
Annual compound
5Y CAGR
+244.0%/yr
Recent acceleration
Percentile
P100
Near historical high
vs 5Y Ago
481.7x
Strong expansion
Streak
1 yr
Consecutive growthElevated
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 0.25 | +3826.5% |
| 2024 | 0.01 | -15.1% |
| 2023 | 0.01 | +29.1% |
| 2022 | 0.01 | +100.4% |
| 2021 | -1.29 | -249640.9% |
| 2020 | 0.00 | - |